The FDA Has Changed the Rules on HRT — Here's What It Means for You

After more than two decades, the warnings that kept millions of women away from hormone replacement therapy have been removed. This is what the science actually says — and why it matters.

If you've ever asked your doctor about hormone replacement therapy and been met with hesitation, caution, or an outright 'no' — you're not alone. For more than 20 years, HRT has been shrouded in fear, largely off the table for many women, and treated with a level of medical wariness that, as it turns out, wasn't fully warranted.

That's now beginning to change. In November 2025, the US Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS) announced a landmark decision: the removal of the so-called 'black box' warnings that have been printed on HRT products since 2003. By February 2026, those label changes officially went into effect.

Here at Ivoryrose, we work alongside women at every stage of life — including the often-confusing, often-invisible transition through perimenopause and menopause. This update matters to us, and we want to help you understand what it actually means for your health.

First, a bit of background

In 2002, a large study known as the Women's Health Initiative (WHI) set off alarm bells about HRT. The study suggested a potential increased risk of breast cancer, and the FDA responded in 2003 by adding black box warnings — the most serious level of warning a drug can carry — to all estrogen- containing products.

The result? HRT use plummeted. Women stopped asking for it. Doctors stopped prescribing it. And an entire generation of women navigated menopause without a treatment that could have significantly improved their quality of life — and, we now know, their long-term health.

The problem? The original study had significant limitations. The increased breast cancer risk it found was not statistically significant, and much of the concern was later linked to a specific type of progesterone — medroxyprogesterone acetate — that isn't commonly used in modern hormone therapy formulations.

What the FDA has actually done

Following a comprehensive review of the scientific literature, an expert panel, and a public comment period, the FDA has now requested that manufacturers update their HRT labels to remove warnings related to:

  • Cardiovascular disease and stroke

  • Breast cancer

  • Probable dementia

    Also removed is the longstanding recommendation to use HRT at the lowest possible dose for the shortest possible time — guidance that, for many women, translated to feeling rushed off a treatment that was actually helping them.

    Note: The warning for endometrial cancer in women with a uterus who use estrogen-only therapy (without progesterone) remains in place — and rightly so. This is a well-established and clinically important consideration.

    What the updated evidence actually tells us

    The science on HRT has continued to evolve over the past two decades, and the picture is increasingly positive — particularly for women who begin therapy within the right window. Here's what the updated data shows:

  • A 25–50% reduction in cardiovascular disease risk

  • A reduction in Alzheimer's disease risk of approximately 35%

  • A 50–60% reduction in bone fracture risk

  • Reductions in all-cause mortality when started at the right time

    These are not small numbers. These are meaningful, life-changing outcomes — and they were being withheld from women based on warnings that didn't reflect the full picture.

    Timing matters — here's what to know

    The evidence consistently points to the importance of starting HRT within the right window. The FDA's updated guidance reflects this, noting that the greatest benefit is seen when HRT is initiated within 10 years of the onset of menopause, or before the age of 60.

    This is often referred to as the 'timing hypothesis', and it's an important reason why understanding where you are in your hormonal transition matters — not just for symptom relief, but for your long-term health.

    It's also why the early, often subtle signs of perimenopause are worth paying attention to. Perimenopause can begin years — sometimes a decade — before your final period. The changes are often quiet at first: disrupted sleep, mood shifts, brain fog, changes in your cycle. Easy to write off as stress. Easy to miss entirely.

    What this means for you, practically

This is not a directive to start HRT. It is an invitation to have a better conversation.

HRT is not right for every woman. There are individual health histories, personal preferences, and other factors that your GP or specialist will consider with you. But what this change does mean is that the conversation can now happen without the shadow of outdated, overstated warnings hanging over it.

If you've been told HRT isn't for you based on old guidelines — it may be worth revisiting that conversation. If you've been curious but nervous — now you have better information to go in with. And if you're only just beginning to notice changes in your body and wondering whether perimenopause might be on the horizon — this is exactly the right time to start exploring your options.

How Ivoryrose can help

While HRT is a conversation to have with your GP or menopause specialist, there's so much more to navigating this season well — and that's where we come in.

As oestrogen declines, women often notice changes that go far beyond hot flushes. Pelvic floor strength, bladder control, bone density, joint comfort, body composition, sleep, and mood — all of these are influenced by hormonal shifts, and all of these are areas where women's health physiotherapy and evidence-based exercise with one of our exercise physiologists can make a real difference.

Our team specialises in supporting women through perimenopause and menopause with:

  • Pelvic floor assessment and targeted strengthening

  • Bladder and bowel management

  • Exercise programming to support bone density, muscle mass and energy

  • Support for joint pain, stiffness and pelvic discomfort

  • Education, clarity and a genuinely individual approach to your care

    Whether you're just starting to notice changes, in the thick of it, or well into post-menopause, you don't have to navigate this alone.

    You deserve accurate information. You deserve to feel strong, clear and in control of your body — whatever season of life you're in.

    Book an appointment with our team at Ivoryrose, or explore our perimenopause and menopause support page to learn more.

Kathryn Warr